352 related articles for article (PubMed ID: 14644119)
81. Primary Sarcomatoid Tumor of the Bladder: A Different Entity but the Same Approach?
Molina-Cerrillo J; Martínez-Sáez O; Alonso-Gordoa T; Tirado-Zambrano P; Delgado-Vargas B; Earl J; Grande E
Clin Genitourin Cancer; 2015 Dec; 13(6):493-8. PubMed ID: 26027772
[TBL] [Abstract][Full Text] [Related]
82. Pathologic features of bladder tumors after nephroureterectomy or segmental ureterectomy for upper urinary tract transitional cell carcinoma.
Raman JD; Sosa RE; Vaughan ED; Scherr DS
Urology; 2007 Feb; 69(2):251-4. PubMed ID: 17320658
[TBL] [Abstract][Full Text] [Related]
83. [Non-epithelial tissue tumors of the urinary bladder].
Xu AX; Wang XX; Hong BF; Ye LY; Zhang L
Zhonghua Wai Ke Za Zhi; 2003 Jul; 41(7):530-3. PubMed ID: 12921662
[TBL] [Abstract][Full Text] [Related]
84. Synchronous squamous cell carcinoma of the kidney, squamous cell carcinoma of the ureter, and sarcomatoid carcinoma of the urinary bladder: a case report.
Terada T
Pathol Res Pract; 2010 Jun; 206(6):379-83. PubMed ID: 19766408
[TBL] [Abstract][Full Text] [Related]
85. Aggressive behavior of low-grade Ta papillary urothelial bladder neoplasm in a 17-year-old patient.
Labanaris AP; Labanaris PG; Gitsos G; Kühn R; Schott GE; Zugor V
Urology; 2007 May; 69(5):983.e1-2. PubMed ID: 17482953
[TBL] [Abstract][Full Text] [Related]
86. Bladder tumours in Enugu, Nigeria.
Aghaji AE; Mbonu OO
Br J Urol; 1989 Oct; 64(4):399-402. PubMed ID: 2819392
[TBL] [Abstract][Full Text] [Related]
87. Clinical outcome of tumor recurrence for Ta, T1 non-muscle invasive bladder cancer from the data on registered bladder cancer patients in Japan: 1999-2001 report from the Japanese Urological Association.
Kikuchi E; Fujimoto H; Mizutani Y; Okajima E; Koga H; Hinotsu S; Shinohara N; Oya M; Miki T;
Int J Urol; 2009 Mar; 16(3):279-86. PubMed ID: 19207609
[TBL] [Abstract][Full Text] [Related]
88. The distribution pattern of myofibroblasts in the stroma of human bladder carcinoma depends on their invasiveness.
Shimasaki N; Kuroda N; Miyazaki E; Hayashi Y; Toi M; Hiroi M; Enzan H; Shuin T
Histol Histopathol; 2006 Apr; 21(4):349-53. PubMed ID: 16437379
[TBL] [Abstract][Full Text] [Related]
89. Urachal adenocarcinoma.
Paras FA; Maclennan GT
J Urol; 2008 Aug; 180(2):720. PubMed ID: 18554640
[No Abstract] [Full Text] [Related]
90. Prognostic significance in substaging ofT1 urinary bladder urothelial carcinoma on transurethral resection.
Chang WC; Chang YH; Pan CC
Am J Surg Pathol; 2012 Mar; 36(3):454-61. PubMed ID: 22261706
[TBL] [Abstract][Full Text] [Related]
91. Overexpression of semaphorin 3A in patients with urothelial cancer.
Vadasz Z; Rubinstein J; Bejar J; Sheffer H; Halachmi S
Urol Oncol; 2018 Apr; 36(4):161.e1-161.e6. PubMed ID: 29288007
[TBL] [Abstract][Full Text] [Related]
92. A rare case of synchronous leiomyosarcoma and urothelial cancer of the bladder.
Bakaris S; Resim S; Tasci AI; Demirpolat G
Can J Urol; 2008 Feb; 15(1):3920-3. PubMed ID: 18304405
[TBL] [Abstract][Full Text] [Related]
93. Total cystectomy versus bladder preservation therapy for locally invasive bladder cancer: effect of combined therapy using balloon-occluded arterial infusion of anticancer agent and hemodialysis with concurrent radiation.
Azuma H; Yamamoto K; Inamoto T; Ibuki N; Kotake Y; Sakamoto T; Kiyama S; Ubai T; Takahara K; Segawa N; Narumi Y; Katsuoka Y
Am J Clin Oncol; 2009 Dec; 32(6):592-606. PubMed ID: 19593084
[TBL] [Abstract][Full Text] [Related]
94. Use of potentially curative therapies for muscle-invasive bladder cancer in the United States: results from the National Cancer Data Base.
Gray PJ; Fedewa SA; Shipley WU; Efstathiou JA; Lin CC; Zietman AL; Virgo KS
Eur Urol; 2013 May; 63(5):823-9. PubMed ID: 23200811
[TBL] [Abstract][Full Text] [Related]
95. Carcinosarcoma of the bladder.
Sakkas G; Kastriotis I; Karagiannis A; Kosmaoglou E; Demonakou M; Tamvakis M
Int Urol Nephrol; 1995; 27(1):57-60. PubMed ID: 7615372
[TBL] [Abstract][Full Text] [Related]
96. Survival experience of black patients and white patients with bladder carcinoma.
Prout GR; Wesley MN; McCarron PG; Chen VW; Greenberg RS; Mayberry RM; Edwards BK
Cancer; 2004 Feb; 100(3):621-30. PubMed ID: 14745881
[TBL] [Abstract][Full Text] [Related]
97. Prevalence, management, and prognosis of bladder cancer in patients with neurogenic bladder: A systematic review.
Ismail S; Karsenty G; Chartier-Kastler E; Cussenot O; Compérat E; Rouprêt M; Phé V
Neurourol Urodyn; 2018 Apr; 37(4):1386-1395. PubMed ID: 29168217
[TBL] [Abstract][Full Text] [Related]
98. [Bladder cancer and neurogenic bladder].
Ruffion A; Comperat E; Roupret M; Chartier-Kastler E
Prog Urol; 2007 May; 17(3):431-5. PubMed ID: 17622071
[TBL] [Abstract][Full Text] [Related]
99. Secondary tumors of the bladder: A survival outcome study.
Hamza A; Hwang MJ; Czerniak BA; Guo CC
Ann Diagn Pathol; 2020 Oct; 48():151593. PubMed ID: 32836180
[TBL] [Abstract][Full Text] [Related]
100. Current Advances in the Management of Nonurothelial Subtypes of Bladder Cancer.
Vlachou E; Johnson BA; Baraban E; Nadal R; Hoffman-Censits J
Am Soc Clin Oncol Educ Book; 2024 Jun; 44(3):e438640. PubMed ID: 38870453
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
